These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16619017)

  • 1. Fishing and frogging for anti-angiogenic drugs.
    De Smet F; Carmeliet P; Autiero M
    Nat Chem Biol; 2006 May; 2(5):228-9. PubMed ID: 16619017
    [No Abstract]   [Full Text] [Related]  

  • 2. Mammalian tumor xenografts induce neovascularization in zebrafish embryos.
    Nicoli S; Ribatti D; Cotelli F; Presta M
    Cancer Res; 2007 Apr; 67(7):2927-31. PubMed ID: 17409396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid analysis of angiogenesis drugs in a live fluorescent zebrafish assay.
    Cross LM; Cook MA; Lin S; Chen JN; Rubinstein AL
    Arterioscler Thromb Vasc Biol; 2003 May; 23(5):911-2. PubMed ID: 12740225
    [No Abstract]   [Full Text] [Related]  

  • 4. Rosuvastatin, identified from a zebrafish chemical genetic screen for antiangiogenic compounds, suppresses the growth of prostate cancer.
    Wang C; Tao W; Wang Y; Bikow J; Lu B; Keating A; Verma S; Parker TG; Han R; Wen XY
    Eur Urol; 2010 Sep; 58(3):418-26. PubMed ID: 20605315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of phosphorylase kinase as a novel therapeutic target through high-throughput screening for anti-angiogenesis compounds in zebrafish.
    Camus S; Quevedo C; Menéndez S; Paramonov I; Stouten PF; Janssen RA; Rueb S; He S; Snaar-Jagalska BE; Laricchia-Robbio L; Izpisua Belmonte JC
    Oncogene; 2012 Sep; 31(39):4333-42. PubMed ID: 22179836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting angiogenesis in head and neck cancer.
    Seiwert TY; Cohen EE
    Semin Oncol; 2008 Jun; 35(3):274-85. PubMed ID: 18544442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current concerns and challenges regarding tailored anti-angiogenic therapy in cancer.
    Roukos DH; Tzakos A; Zografos G
    Expert Rev Anticancer Ther; 2009 Oct; 9(10):1413-6. PubMed ID: 19828000
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies.
    Shojaei F; Ferrara N
    Drug Resist Updat; 2008 Dec; 11(6):219-30. PubMed ID: 18948057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fishing anti(lymph)angiogenic drugs with zebrafish.
    García-Caballero M; Quesada AR; Medina MA; Marí-Beffa M
    Drug Discov Today; 2018 Feb; 23(2):366-374. PubMed ID: 29081356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour angiogenesis: its mechanism and therapeutic implications in malignant gliomas.
    Wong ML; Prawira A; Kaye AH; Hovens CM
    J Clin Neurosci; 2009 Sep; 16(9):1119-30. PubMed ID: 19556134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roche consolidates grip on anti-angiogenesis market.
    Moran N
    Nat Biotechnol; 2008 Oct; 26(10):1055-6. PubMed ID: 18846054
    [No Abstract]   [Full Text] [Related]  

  • 12. Angiogenesis and anti-angiogenesis in hepatocellular carcinoma.
    Ribatti D; Vacca A; Nico B; Sansonno D; Dammacco F
    Cancer Treat Rev; 2006 Oct; 32(6):437-44. PubMed ID: 16870349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-angiogenic therapy: Prospects for treatment of ocular tumors.
    Rosenblatt MI; Azar DT
    Semin Ophthalmol; 2006; 21(3):151-60. PubMed ID: 16912013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microtubule-targeting agents in angiogenesis: where do we stand?
    Pasquier E; Honoré S; Braguer D
    Drug Resist Updat; 2006; 9(1-2):74-86. PubMed ID: 16714139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-angiogenic function of tocotrienol.
    Miyazawa T; Shibata A; Nakagawa K; Tsuzuki T
    Asia Pac J Clin Nutr; 2008; 17 Suppl 1():253-6. PubMed ID: 18296349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automated, quantitative screening assay for antiangiogenic compounds using transgenic zebrafish.
    Tran TC; Sneed B; Haider J; Blavo D; White A; Aiyejorun T; Baranowski TC; Rubinstein AL; Doan TN; Dingledine R; Sandberg EM
    Cancer Res; 2007 Dec; 67(23):11386-92. PubMed ID: 18056466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zebrafish (Danio rerio) embryo as a platform for the identification of novel angiogenesis inhibitors of retinal vascular diseases.
    Rezzola S; Paganini G; Semeraro F; Presta M; Tobia C
    Biochim Biophys Acta; 2016 Jul; 1862(7):1291-6. PubMed ID: 27085972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Angiogenic inhibitors and radiotherapy: from the concept to the clinical trial].
    Cohen-Jonathan Moyal E
    Cancer Radiother; 2009 Oct; 13(6-7):562-7. PubMed ID: 19695923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Angiogenesis inhibitors and radiation therapy: concept and preliminary results].
    Mazeron R; Bourhis J; Deutsch E
    Bull Cancer; 2009 Mar; 96(3):299-310. PubMed ID: 19318308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-angiogenic drugs: from bench to clinical trials.
    Quesada AR; Muñoz-Chápuli R; Medina MA
    Med Res Rev; 2006 Jul; 26(4):483-530. PubMed ID: 16652370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.